4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001909680-26-000002
Chief Scientific Officer sold 23,447 shares at $10.06 ($235,769)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barone Francesca Chief Scientific Officer | 2026-06-29 | Sale 10b5-1 | −23,447 | $10.06 | $235,769 | 77,362 | D: show line 1 in the form |
| Open-market sales · 23,447 sh · avg $10.06 · $235,769 | |||||||
Loading xslF345X06/ownership.xml…